Maravai LifeSciences Q3 Earnings Preview Includes EPS Estimate
Maravai LifeSciences is scheduled to report Q3 results on November 04 after market close. Revenue is estimated at 43.56 million USD and EPS at (0.06) USD.
Related stories
UL Solutions Reports Quarterly Results for Period Ended September 30
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
Waters Corp Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
EBS: trading halted on NYSE — additional information requested (last $6.46)
NYSE halted trading in EBS (additional information requested). Last price $6.46.
L impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
Nasdaq Composite Rises 114.76 Points (0.46%)
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
S&P 500 Rises 14.11 Points (0.19%)
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
DJIA Falls 188.18 Points (0.36%)
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC